Nolato AB: Earnings Call Shows Strength Beyond Q4

Nolato AB Class B (($SE:NOLA.B)) has held its Q4 earnings call. Read on for the main highlights of the call.

Nolato AB Class B Balances Strong Yearly Gains With Temporary Q4 Headwinds

Nolato’s latest earnings call painted a broadly upbeat picture for the full year, even as the fourth quarter showed some short-term softness. Management highlighted higher full‑year sales, double‑digit growth in operating profit, an improved margin profile, rising earnings per share, a larger dividend and stronger returns on capital. While Q4 results were dampened by currency headwinds, production start‑up costs, year‑end volume softness and volatile precious metal prices, these were framed as temporary and manageable issues, outweighed by the company’s solid annual performance and robust financial position.

Q4 Sales Growth Held Back by Currency Headwinds

Nolato reported Q4 net sales of SEK 2.272 billion, equivalent to roughly 2% growth when adjusted for currency. However, a steep 7% FX headwind significantly masked the underlying momentum. Management stressed that excluding these currency effects, the quarter still showed modest growth, with demand patterns broadly stable outside of holiday‑related slowdowns. The company’s ability to grow in constant currency terms, despite macro volatility, underpins its confidence in the resilience of its core markets.

Full-Year 2025: Higher Sales, Margin Expansion and Profit Growth

For the full year 2025, Nolato delivered sales close to SEK 9.5 billion, up about 2% on a currency‑adjusted basis. More importantly for investors, operating profit rose 11%, and the EBITA margin improved to 11.3%, up from 9.9% the previous year—an increase of 1.4 percentage points. This margin expansion signals that the company is executing well on pricing, mix and efficiency, even as some end markets remain uneven. The improved profitability suggests a healthier, more scalable business model, with better earnings power per krona of revenue.

EPS Growth and a Higher Dividend Signal Confidence

Earnings per share came in at SEK 2.88 for 2025, and the board proposed increasing the dividend to SEK 1.70 per share from SEK 1.50. While the payout ratio edged down to 59% from 61%, this still represents a meaningful distribution of profits to shareholders while preserving capital for growth investments. The combination of rising EPS and a higher dividend indicates management’s confidence in the company’s cash‑generating ability and in the sustainability of earnings.

Medical Solutions Drives Group Scale and Profitable Growth

Medical Solutions has become the clear growth engine, generating just above SEK 1.3 billion in Q4 sales—about 5% growth adjusted for currency—and now accounting for 58% of group revenue. The segment’s margin rose to 11.6%, an improvement of 0.4 percentage points from the prior year, even after absorbing temporary start‑up costs in the U.S. Nolato is expanding capacity in Hungary, Poland and Malaysia, bolstering its global footprint and positioning the division to capture growing demand across medical devices and related applications. This increasing scale in a structurally attractive, less cyclical sector is a key part of the group’s long‑term investment case.

Engineered Solutions: Mixed Top Line But Better Margins

Engineered Solutions delivered close to SEK 1 billion in Q4 sales and now represents 42% of group revenue. On a currency‑adjusted basis, the division saw roughly a 1% decline in sales, with some subsegments affected by inventory adjustments and weaker volumes, particularly around year‑end. Despite this, the business area’s margin improved to 9.9% from 9.2%, helped by a strong performance in the Materials subsegment and operational improvements. This margin uplift suggests the division can generate better profitability even through modest volume softness, though near‑term volatility—especially in materials pricing—remains a factor to monitor.

Materials Subsegment Delivers Growth Amid Commodity Volatility

Within Engineered Solutions, the Materials subsegment stood out with around 10% sales growth adjusted for currency in Q4. However, sharp increases in silver and other precious metal prices significantly pressured margins. Management estimated that metal pricing and related customer shutdowns were the main drivers behind a roughly 1 percentage point negative impact on the Engineered business area margin. Price adjustments and pass‑through mechanisms are underway, but timing mismatches between cost spikes and customer price changes caused short‑term pain. Investors should expect some continued volatility here, even as underlying demand looks solid.

Strong Cash Generation and Disciplined Capital Allocation

Operating cash flow reached SEK 310 million in Q4, underscoring Nolato’s strong cash‑generating profile. Capital expenditure for the quarter was SEK 146 million, with full‑year 2026 CapEx guided in the SEK 650–700 million range. Approximately SEK 100 million of that is earmarked for the ongoing Hungarian expansion. The company’s ability to fund growth investments while increasing dividends—and still maintain a strong balance sheet capable of supporting acquisitions—underscores disciplined capital allocation and gives management flexibility to pursue both organic and inorganic growth.

Return on Capital Employed Strengthens

Return on capital employed improved to 14.2% for 2025, reflecting better efficiency in how Nolato uses its asset base to generate profit. This higher ROCE, combined with expanding margins, indicates that recent investments and operational initiatives are paying off. For investors, it is a clear sign that the company is not just growing, but doing so in a value‑creating way.

Sustainability Achievements Add Strategic Edge

Nolato reported significant progress on its sustainability agenda. Scope 1 and 2 emissions have been reduced by 96% versus the 2021 base year, far surpassing the 2030 target of a 70% reduction. Upstream Scope 3 emissions are down by 30%, already beating the 25% target. Furthermore, the company’s net‑zero 2045 target has been approved by the Science Based Targets initiative, adding external validation to its climate strategy. These achievements support long‑term risk management, can enhance customer relationships—especially in regulated and ESG‑sensitive industries—and may strengthen Nolato’s positioning in future tenders and partnerships.

Q4 Profitability Hit by Currency, Start-Up Costs and Low Volumes

Despite the strong full‑year story, Q4 EBITA slipped slightly to SEK 236 million from SEK 240 million, with the margin at 10.4%. Currency effects alone, estimated at around a 6–7% headwind and roughly SEK 14 million in the quarter, weighed on reported profit. Higher group‑level costs, including M&A‑related expenses, added further pressure, with management citing temporary negative effects of SEK 25–30 million versus Q3. Taken together, these factors turned what was fundamentally a stable quarter in operational terms into one that looked softer in reported figures.

Temporary Start-Up Costs and Holiday Volume Weakness

Multiple production start‑ups in the U.S., particularly in the medical segment, led to elevated temporary costs that shaved about 0.5 percentage points off the medical margin. Management expects some of these start‑up expenses to persist into Q1 2026 before normalizing as volumes ramp up. Additionally, year‑end holidays resulted in weaker volumes—most notably in Engineered Hygiene—further pressuring margins. The company does not anticipate a major volume “catch‑up” in Q1; instead, it expects a more normalized quarter without a sharp rebound from the holiday lull.

Forward-Looking Outlook: Normalization Ahead, With Capacity for M&A

Management guided that the temporary headwinds seen in Q4—U.S. start‑up costs, lower year‑end volumes and higher precious metal costs—will partly carry into Q1 2026, implying that the first quarter will not be a bounce‑back period but rather a more typical trading environment. However, the company expects pricing actions and contract mechanisms to gradually offset metal price spikes and currency pressures. With full‑year 2025 EBITA margin at 11.3% (up 1.4 percentage points), EPS at SEK 2.88, and a rising dividend, Nolato believes it has solid earnings momentum entering 2026. A strong balance sheet and ample cash flow give management room to pursue further acquisitions alongside ongoing expansions in Hungary, Poland and Malaysia, supporting a continued growth and margin‑improvement trajectory.

In summary, Nolato’s earnings call revealed a company that is executing well at the full‑year level, with rising margins, stronger returns, a growing medical business and impressive sustainability progress. Q4’s softer optics largely reflect temporary, external and start‑up‑related factors rather than structural weakness. For investors, the message was that the underlying trend in profitability and capital efficiency is positive, backed by a solid financial position and a clear strategy for both organic expansion and M&A‑driven growth.